Amy Brideau-Andersen

578 total citations
20 papers, 418 citations indexed

About

Amy Brideau-Andersen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Amy Brideau-Andersen has authored 20 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Amy Brideau-Andersen's work include Botulinum Toxin and Related Neurological Disorders (16 papers), Neurological disorders and treatments (9 papers) and Hereditary Neurological Disorders (5 papers). Amy Brideau-Andersen is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (16 papers), Neurological disorders and treatments (9 papers) and Hereditary Neurological Disorders (5 papers). Amy Brideau-Andersen collaborates with scholars based in United States, Ireland and Austria. Amy Brideau-Andersen's co-authors include Sharookh B. Kapadia, Francis V. Chisari, Mitchell F. Brin, Lance E. Steward, Ron S. Broide, Catherine Rhéaume, J. Oliver Dolly, Mark Washburn, Wolfgang Liedtke and Carlene Moore and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Pain.

In The Last Decade

Amy Brideau-Andersen

14 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Brideau-Andersen United States 7 250 101 92 74 74 20 418
Patricia A. Thibault Canada 14 370 1.5× 163 1.6× 87 0.9× 17 0.2× 41 0.6× 26 601
Aurélia Cassany France 10 217 0.9× 91 0.9× 49 0.5× 7 0.1× 153 2.1× 11 356
Edward M. Murray United States 10 89 0.4× 236 2.3× 227 2.5× 12 0.2× 25 0.3× 12 461
Rebecca S. Brown United States 12 219 0.9× 88 0.9× 36 0.4× 104 1.4× 40 0.5× 15 620
Jean Luc Darlix France 8 303 1.2× 54 0.5× 30 0.3× 23 0.3× 19 0.3× 8 377
Lisa N. Akhtar United States 7 153 0.6× 124 1.2× 11 0.1× 14 0.2× 48 0.6× 11 557
Sriparna Mukherjee India 13 191 0.8× 78 0.8× 9 0.1× 24 0.3× 37 0.5× 19 580
Stina L. Urban United States 8 85 0.3× 132 1.3× 22 0.2× 26 0.4× 26 0.4× 12 508
Jessica D. Briley United States 4 251 1.0× 108 1.1× 60 0.7× 7 0.1× 14 0.2× 11 469
Ton Kos Netherlands 9 63 0.3× 178 1.8× 191 2.1× 15 0.2× 23 0.3× 11 434

Countries citing papers authored by Amy Brideau-Andersen

Since Specialization
Citations

This map shows the geographic impact of Amy Brideau-Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Brideau-Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Brideau-Andersen more than expected).

Fields of papers citing papers by Amy Brideau-Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Brideau-Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Brideau-Andersen. The network helps show where Amy Brideau-Andersen may publish in the future.

Co-authorship network of co-authors of Amy Brideau-Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Brideau-Andersen. A scholar is included among the top collaborators of Amy Brideau-Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Brideau-Andersen. Amy Brideau-Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barragán‐Iglesias, Paulino, et al.. (2025). Botulinum Neurotoxin A Signaling in Pain Modulation Within Human Sensory Neurons. Journal of Neurochemistry. 169(9). e70236–e70236.
4.
Schain, Aaron, Diego Fajardo, Andrew M. Strassman, et al.. (2025). OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female mice. Cephalalgia. 45(9). 2235423786–2235423786.
5.
Canty, David, et al.. (2024). Evaluation of Botulinum Neurotoxin Type E Preparation (TrenibotulinumtoxinE) in the Mouse Digit Abduction Score (DAS) Assay. Toxicon. 237. 107377–107377. 1 indexed citations
6.
Brin, Mitchell F., et al.. (2024). Update on Non-Interchangeability of Botulinum Neurotoxin Products. Toxins. 16(6). 266–266. 11 indexed citations
7.
Rhéaume, Catherine, et al.. (2023). A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA. Clinical Cosmetic and Investigational Dermatology. Volume 16. 581–591. 6 indexed citations
8.
Brideau-Andersen, Amy, et al.. (2023). OnabotulinumtoxinA effects on trigeminal nociceptors. Cephalalgia. 43(2). 2205186739–2205186739. 12 indexed citations
9.
Brideau-Andersen, Amy, J. Oliver Dolly, & Mitchell F. Brin. (2023). Botulinum neurotoxins: Future innovations. Medicine. 102(S1). e32378–e32378. 5 indexed citations
10.
Speciale, Gaetano, Madison H. Fletcher, Yi Liu, et al.. (2022). Reengineering the specificity of the highly selective Clostridium botulinum protease via directed evolution. Scientific Reports. 12(1). 9956–9956. 6 indexed citations
11.
Brami‐Cherrier, Karen, et al.. (2022). Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis. Toxins. 14(10). 708–708. 5 indexed citations
13.
Steward, Lance E., et al.. (2021). Botulax displays lower enzymatic activity when compared to onabotulinumtoxinA in a light chain activity assay. Toxicon. 190. S66–S66. 1 indexed citations
15.
Melo‐Carrillo, Agustin, Andrew M. Strassman, Aaron Schain, et al.. (2021). OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood–brain barrier. Pain. 162(9). 2418–2427. 4 indexed citations
16.
Steward, Lance E., Mitchell F. Brin, & Amy Brideau-Andersen. (2020). Novel Native and Engineered Botulinum Neurotoxins. Handbook of experimental pharmacology. 263. 63–89. 22 indexed citations
17.
Wang, Joanne, Catherine Rhéaume, Lance E. Steward, et al.. (2020). OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays. Toxins. 12(6). 393–393. 10 indexed citations
19.
Brideau-Andersen, Amy, et al.. (2006). 10 Directed evolution of novel gene shuffled interferon alphas for the treatment of hepatitis C. Journal of Hepatology. 44. S6–S7. 2 indexed citations
20.
Kapadia, Sharookh B., Amy Brideau-Andersen, & Francis V. Chisari. (2003). Interference of hepatitis C virus RNA replication by short interfering RNAs. Proceedings of the National Academy of Sciences. 100(4). 2014–2018. 323 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026